Results 21 to 30 of about 24,686 (257)

Advanced glycation end products (AGEs) activate mast cells [PDF]

open access: yesBritish Journal of Pharmacology, 2010
BACKGROUND AND PURPOSEAdvanced glycation endproducts (AGEs) represent one of the many types of chemical modifications that occur with age in long‐lived proteins. AGEs also accumulate in pathologies such as diabetes, cardiovascular diseases, neurodegeneration and cancer. Mast cells are major effectors of acute inflammatory responses that also contribute
E, Sick   +6 more
openaire   +2 more sources

How Can Diet Affect the Accumulation of Advanced Glycation End-Products in the Human Body?

open access: yesFoods, 2016
The accumulation of advanced glycation end products (AGEs) is associated with the complications of diabetes, kidney disease, metabolic disorders and degenerative diseases. It is recognized that the pool of glycation products found in the human body comes
Axel Guilbaud   +3 more
doaj   +1 more source

Histone functions as a cell-surface receptor for AGEs

open access: yesNature Communications, 2022
Advanced glycation end products (AGEs) are believed to be pathogenic molecules that mediate pro-inflammatory responses. Here the authors identify histone as a cell-surface receptor for AGEs and show that AGEs may also be involved in the homeostatic ...
Masanori Itakura   +10 more
doaj   +1 more source

Investigating Bioaccessibility of Advanced Glycation Product Precursors in Gluten-Free Foods Using In Vitro Gastrointestinal System

open access: yesMedicina, 2023
Background and Objectives: Gluten-free products have been produced as part of medical therapy and have gained popularity among individuals seeking weight loss or healthier dietary options.
Yeliz Serin   +2 more
doaj   +1 more source

Enrichment and analysis of glycated proteins

open access: yesReviews in Analytical Chemistry, 2022
Glycation is a spontaneous post-translational modification of lysine, arginine, and the N-terminus of proteins. Protein glycation is closely related to the pathogenesis of human diseases, including diabetes, Alzheimer’s disease, renal disease, and cancer.
Cho Seonghyeon   +5 more
doaj   +1 more source

Advanced glycation end products and their receptor contribute to ovarian ageing [PDF]

open access: yesHuman Reproduction, 2013
Do advanced glycation end products (AGE) and the receptor for advanced glycation end products (RAGE) affect the cells of the human ovarian follicle?AGE accumulate on the surface of ovarian granulosa-lutein (GL) cells and monocytes by binding to RAGE and other receptors with possible functional effects on these cells.AGE and RAGE are expressed in ...
Mette Haug, Stensen   +3 more
openaire   +2 more sources

Antiglycation potential of commercial available extracts of two Indian medicinal plants: Pterocarpus marsupium and Artocarpus lakoocha using advanced glycation end products (AGE) competitive fluorescence assay

open access: yesCogent Food & Agriculture, 2021
Glycation is a non-enzymatic biochemical reaction between reducing sugars and amino acids, causing the crosslinking and rearrangement of glycated proteins, leading to irreversible formation of Advanced Glycation End products (AGEs).
Alpana Pande   +4 more
doaj   +1 more source

Glycation at the Crossroads of Disease Pathogenesis: Mechanistic Insights and Therapeutic Frontiers

open access: yesDiseases
Protein glycation is a nonenzymatic modification that links sugar chemistry to molecular aging and chronic disease. Sequential reactions involving Schiff bases, Amadori products, and reactive α dicarbonyl intermediates generate advanced glycation end ...
Sneha Krishnamoorthi   +2 more
doaj   +1 more source

Pinocembrin Protects from AGE-Induced Cytotoxicity and Inhibits Non-Enzymatic Glycation in Human Insulin

open access: yesCells, 2019
Advanced glycation end products (AGEs) are the end products of the glycation reaction and have a great importance in clinical science for their association with oxidative stress and inflammation, which play a major role in most chronic diseases, such as ...
Margherita Borriello   +2 more
doaj   +1 more source

Advanced Glycation End Products in Age-related Macular Degeneration [PDF]

open access: yesArchives of Ophthalmology, 1998
To investigate the localization of N epsilon-(carboxymethyl)lysine (CML), a component and major immunologic epitope of advanced glycation end products, in aged eyes and choroidal neovascular membranes (CNVMs) surgically excised from eyes with age-related macular degeneration.Immunohistochemistry for CML was performed using 8 snap-frozen, surgically ...
T, Ishibashi   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy